Meletios-Athanasios Dimopoulos Selected Research

pomalidomide

2/2022	Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
1/2021	Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meletios-Athanasios Dimopoulos Research Topics

Disease

37	Neoplasms (Cancer) 08/2023 - 06/2005
30	Multiple Myeloma 02/2024 - 04/2002
20	COVID-19 01/2023 - 08/2020
18	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2015
12	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 11/2009
7	Disease Progression 02/2024 - 06/2005
6	Infections 01/2023 - 12/2020
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 06/2005
5	Carcinoma (Carcinomatosis) 07/2023 - 09/2006
5	Cardiotoxicity 01/2023 - 08/2018
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018 - 02/2007
5	Neoplasm Metastasis (Metastasis) 01/2015 - 11/2009
4	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 01/2021
3	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 09/2004
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2023 - 11/2019
3	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 10/2011
3	Thrombocytopenia (Thrombopenia) 02/2022 - 10/2020
3	Heart Failure 02/2022 - 05/2010
3	Carcinogenesis 08/2021 - 01/2016
3	Ascites 01/2016 - 11/2009
2	Bone Diseases (Bone Disease) 02/2024 - 07/2021
2	Ovarian Epithelial Carcinoma 07/2023 - 01/2023
2	Immunoglobulin Light-chain Amyloidosis 02/2023 - 09/2021
2	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 12/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2022 - 01/2021
2	Pneumonia (Pneumonitis) 02/2022 - 10/2011
2	Smoldering Multiple Myeloma 01/2022 - 01/2020
2	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 08/2021
2	Hypertension (High Blood Pressure) 01/2021 - 12/2020
2	Obesity 01/2021 - 12/2020
2	Thrombosis (Thrombus) 12/2020 - 03/2009
2	Lymphopenia (Lymphocytopenia) 12/2020 - 10/2020
2	POEMS Syndrome (Syndrome, POEMS) 01/2020 - 09/2014
2	Melanoma (Melanoma, Malignant) 11/2019 - 07/2016
2	Lung Neoplasms (Lung Cancer) 04/2018 - 04/2008
2	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

10	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 08/2023 - 09/2004
9	AntibodiesIBA 07/2023 - 08/2020
9	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2008
8	PlatinumIBA 07/2023 - 09/2006
8	Lenalidomide (CC 5013)FDA Link 01/2023 - 10/2011
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 11/2009
8	Neutralizing AntibodiesIBA 01/2023 - 01/2021
7	carfilzomibIBA 09/2023 - 01/2021
7	MicroRNAs (MicroRNA)IBA 01/2023 - 12/2019
6	daratumumabIBA 01/2024 - 01/2020
6	Hormones (Hormone)IBA 01/2023 - 12/2009
6	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 04/2008
5	Proteasome InhibitorsIBA 02/2023 - 01/2021
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 04/2021
5	Monoclonal AntibodiesIBA 05/2022 - 01/2014
4	BNT162 VaccineIBA 01/2023 - 01/2022
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2005
4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2014
4	Messenger RNA (mRNA)IBA 11/2022 - 04/2008
4	VaccinesIBA 11/2022 - 01/2021
3	melflufenIBA 02/2024 - 02/2022
3	isatuximabIBA 09/2023 - 01/2021
3	Phosphotransferases (Kinase)IBA 08/2023 - 07/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023 - 01/2021
3	Rituximab (Mabthera)FDA Link 07/2023 - 05/2006
3	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2016
3	Aromatase InhibitorsIBA 01/2023 - 01/2021
3	Bortezomib (Velcade)FDA Link 01/2023 - 01/2021
3	Cyclin-Dependent Kinase 4IBA 01/2023 - 08/2021
3	pembrolizumabIBA 01/2023 - 04/2018
3	4-azidobenzylcarazolol (pABC)IBA 11/2022 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 01/2012
3	WastewaterIBA 01/2022 - 08/2021
3	ParaffinIBA 10/2021 - 12/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2018
3	EnzymesIBA 11/2009 - 04/2008
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	Transfer RNA (tRNA)IBA 02/2024 - 12/2021
2	Immunomodulating AgentsIBA 01/2024 - 04/2008
2	Antineoplastic Agents (Antineoplastics)IBA 09/2023 - 04/2021
2	belantamab mafodotinIBA 07/2023 - 01/2023
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 10/2014
2	NivolumabIBA 01/2023 - 04/2018
2	palbociclibIBA 01/2023 - 06/2022
2	Immunoglobulin M (IgM)IBA 01/2023 - 05/2006
2	Fulvestrant (Faslodex)FDA Link 06/2022 - 01/2015
2	pomalidomideIBA 02/2022 - 01/2021
2	CytokinesIBA 01/2022 - 03/2014
2	Antiviral Agents (Antivirals)IBA 12/2021 - 12/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 08/2020
2	Thalidomide (Thalomid)FDA Link 01/2021 - 11/2004
2	TOR Serine-Threonine KinasesIBA 04/2019 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 11/2012 - 02/2007
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2011 - 05/2010

Therapy/Procedure

31	Therapeutics 02/2024 - 04/2008
23	Drug Therapy (Chemotherapy) 02/2024 - 04/2002
7	Immunotherapy 01/2023 - 07/2016
3	Aftercare (After-Treatment) 01/2023 - 07/2008
3	Nephrectomy 01/2017 - 06/2005
2	Stem Cell Transplantation 09/2023 - 01/2023
2	Radiotherapy 01/2021 - 08/2018
2	Adjuvant Chemotherapy 11/2020 - 12/2011